Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BICYCLE THERAPEUTICS PLC Director's Dealing 2020

Apr 27, 2020

32777_dirs_2020-04-27_e0379593-6a42-4169-bf26-b9f9fe0f6f81.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: BICYCLE THERAPEUTICS plc (BCYC)
CIK: 0001761612
Period of Report: 2019-06-28

Reporting Person: Lee Kevin (Director, Chief Executive Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-06-28 Stock Option (Right to Buy) $14.00 A 506252 Acquired 2029-06-28 Ordinary Shares (506252) Direct

Footnotes

F1: The original Form 4 inadvertently listed the incorrect date of earliest transaction, transaction date and expiration date. This Form 4 amendment is being filed to accurately reflect the appropriates dates.

F2: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant.